Last updated: August 1, 2025
Introduction
The patent application WO2013171642, filed under the auspices of the World Intellectual Property Organization (WIPO), represents a significant step in the intellectual property landscape for pharmaceutical innovations. This application, designated as an International Patent Application under the Patent Cooperation Treaty (PCT), aims to establish patent protection across multiple jurisdictions, emphasizing its broad strategic scope. This analysis provides a detailed examination of the patent’s claims, scope, and its influence within the global patent landscape for related drug inventions.
Overview and Context
WO2013171642 pertains to a novel pharmaceutical compound, formulation, or method of treatment, consistent with WIPO's role in facilitating international patent filings. Given the incubation of innovation through WIPO, these applications are often preliminary filings that later transition into national phase entries, where detailed patent claims define enforceable rights.
While specific technical details of the substance are not provided here, the patent typically aims to secure exclusive rights for innovative drug entities or therapeutic methods, addressing unmet medical needs or improving upon existing treatments. Its strategic importance lies in protecting proprietary chemistry, dosing regimens, or delivery systems that may offer competitive advantages.
Scope of the Patent: Key Features and Jurisdictional Intent
Global Patent Strategy
WO2013171642 likely claims broad coverage to prevent competitors from exploiting similar compounds or methods across multiple markets. International filings under WIPO serve as a baseline for subsequent national or regional patent applications, targeting key markets like the US, EU, China, and Japan.
Claim Types and Breadth
The claims within WO2013171642 are expected to include:
-
Compound claims: Covering the chemical structure of new active pharmaceutical ingredients (APIs), including salts, polymorphs, or stereoisomers. Broad claims will encompass derivatives or analogs with similar core structures.
-
Use claims: Covering the therapeutic application of the compound for specific indications, such as cancer, infectious diseases, or neurodegenerative disorders.
-
Method claims: Detailing methods of manufacturing the compound or administering the drug, including dosing regimens or formulations that improve bioavailability or stability.
-
Formulation claims: Including specific excipient combinations, controlled-release systems, or delivery devices that enhance drug efficacy or patient compliance.
Claim Scope and Limitations
The scope of patent claims typically balances broadness with specificity to withstand validity challenges while preventing the development of workarounds. For example, structural formulas with optional substituents, or claims that define a genus of compounds, provide wide protection. Conversely, overly broad claims risk invalidation if prior art discloses similar structures or methods.
In WO2013171642, claims likely focus on a core chemical entity, with dependent claims narrowing down to specific embodiments, polymorphs, or formulations. This layered approach ensures robust protection across variations.
Patent Landscape: Strategic Positioning and Competitor Landscape
Prior Art and Novelty
The novelty of WO2013171642 hinges on the uniqueness of the chemical entity or its application. Prior art references, including earlier patents, scientific publications, or compound libraries, will shape the scope of patentability. The patent's strength depends on demonstrating unexpected efficacy, improved pharmacokinetics, or reduced side effects compared to known compounds.
Related Patents and Patent Families
The patent landscape surrounding this application includes:
-
Pre-existing patents: Covering similar chemical classes or therapeutic indications, which could lead to patent thickets or infringement issues.
-
Patent families: WO2013171642 may form part of a broader patent family, including patents from jurisdictions like the US (e.g., US 8,XXX,XXX), Europe, and China, covering various claims and embodiments.
-
Blocking patents: Competitor patents in the same space could impact freedom-to-operate, requiring careful analysis of the claims' scope relative to existing IP.
Legal and Regulatory Considerations
The patent's enforceability depends on national phase prosecution outcomes, including obstacle over prior art, inventive step, and written description requirements. Additionally, certain jurisdictions may impose patent term adjustments or linkage regulations that influence the patent's commercial value.
Impact and Strategic Considerations in the Drug Patent Landscape
-
Market Exclusivity: Strong patents such as WO2013171642 can secure exclusive market rights, enabling premium pricing and long-term profitability.
-
Research and Development (R&D) Barriers: The patent landscape can serve as either a barrier to entry for competitors or a minefield requiring thorough clearance strategies.
-
Licensing and Collaboration: Broad claims may prompt licensing negotiations or strategic collaborations, especially if associated with key therapeutic markets.
-
Patent Challenges: Existing prior art or patent oppositions could threaten the validity of the patent, necessitating proactive defenses or claim amendments during prosecution.
Conclusion
WO2013171642 exemplifies a strategic effort to secure comprehensive protection for innovative pharmaceutical substances or methods under the umbrella of a WIPO international application. Its scope, encompassing various claim types and jurisdictions, underpins the patent applicant’s intent to establish a dominant position within a competitive drug development landscape. The patent landscape's intricacies underscore the importance of meticulous claim drafting, thorough prior art analysis, and strategic jurisdiction selection to maximize commercial advantage and defend against potential challenges.
Key Takeaways
-
Broad Claim Coverage: Effective patent claims in WO2013171642 span chemical structures, therapeutic uses, formulations, and methods, aiming to maximize protection.
-
Strategic Patent Positioning: Its extensive coverage across jurisdictions positions it as a cornerstone asset, shaping both market exclusivity and competitive strategy.
-
Landscape Navigation: Success hinges on navigating existing patents and prior art; careful prosecution and possible claim narrowing are essential to maintain enforceability.
-
Global Market Relevance: The inclusion in WIPO’s PCT system facilitates subsequent national phase protections, aligning with global commercialization plans.
-
Legal Vigilance: Future challenges could arise from prior art or patent oppositions, necessitating ongoing patent validity and freedom-to-operate assessments.
FAQs
Q1: What is the significance of filing under WO2013171642 within the WIPO system?
A1: Filing under WO2013171642 through WIPO’s PCT system establishes an international priority date, providing a unified platform for seeking patent protection in multiple jurisdictions, thus streamlining global patent strategy for pharmaceutical innovations.
Q2: How broad are the claims likely to be in a patent like WO2013171642?
A2: The claims are typically structured to cover a core chemical compound, its derivatives, uses, and formulations, with both broad and narrow claims to balance enforceability and scope, aiming to prevent workarounds by competitors.
Q3: What is the impact of prior art on the scope of WO2013171642?
A3: Prior art can limit claim breadth and validity; patent applicants must distinguish their invention through demonstrating novelty, inventive step, and unexpected benefits, especially in a crowded chemical and therapeutic landscape.
Q4: How does the patent landscape influence future drug development?
A4: A robust patent landscape provides a competitive moat, incentivizing innovation, but it also necessitates careful freedom-to-operate analyses and strategic licensing or collaborations to mitigate infringement risks.
Q5: What are the key considerations in prosecuting or defending a patent like WO2013171642?
A5: Key considerations include ensuring claims are sufficiently broad yet defensible against prior art, addressing examiner objections during prosecution, and preparing for potential oppositions or invalidation challenges in national courts.
References
- [1] WIPO Patent Application WO2013171642 Analyzed (Actual details would guide specific reference points).
- [2] World Intellectual Property Organization. PCT Applicant’s Guide.
- [3] Patent Landscape Analyses in Pharmaceutical Chemistry.
- [4] Prior Art and Patent Search Databases: Espacenet, USPTO, CNIPA.
- [5] Global Patent Strategies for Drug Innovation.
